Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 5.22%
- Poor long term growth as Operating profit has grown by an annual rate 33.88% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 2.89
The company has declared Positive results for the last 4 consecutive quarters
Stock is technically in a Mildly Bullish range
With ROE of 11.1, it has a Very Attractive valuation with a 1.1 Price to Book Value
Majority shareholders : Promoters
Market Beating Performance
Stock DNA
Specialty Chemicals
INR 58 Cr (Micro Cap)
10.00
45
0.00%
-0.04
11.05%
1.07
Total Returns (Price + Dividend) 
Hardcast.& Waud for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Hardcastle & Waud Mfg Co Ltd Valuation Shifts Signal Renewed Price Attractiveness
Hardcastle & Waud Mfg Co Ltd has witnessed a significant shift in its valuation parameters, moving from a fair to a very attractive rating. This change is underpinned by a notable improvement in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap specialty chemicals company favourably against its peers and historical benchmarks.
Read More
Hardcastle & Waud Mfg Co Ltd is Rated Hold
Hardcastle & Waud Mfg Co Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 October 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing.
Read More
Hardcastle & Waud Mfg Co Ltd is Rated Hold
Hardcastle & Waud Mfg Co Ltd is rated Hold by MarketsMOJO. This rating was last updated on 25 May 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 12 October 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read More Announcements 
Board Meeting Intimation for Consider Interalia Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2026.
23-Oct-2026 | Source : BSEHardcastle & Waud Manufacturing Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 inter alia to consider and approve 1. interalia Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Oct-2026 | Source : BSECertificate under Regulation 74(5) of the Securities and Exchange Board of India ( Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026.
Shareholder Meeting / Postal Ballot-Outcome of AGM
01-Oct-2026 | Source : BSE80th Annual General Meeting - Voting Results
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.08%)
Held by 0 FIIs
Jeevdani Business Ventures Limited (49.98%)
Rashi Fincorp Ltd. (8.12%)
14.89%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 34.44% vs -28.27% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 26.17% vs -47.80% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 58.61% vs 8.76% in Sep 2024
Growth in half year ended Sep 2025 is 150.85% vs -53.17% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 76.21% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 140.83% vs -40.89% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 80.14% vs 8.87% in Mar 2025
YoY Growth in year ended Mar 2026 is 282.17% vs -50.00% in Mar 2025